ObjectivesTwo nucleos(t)ide reverse-transcriptase inhibitors (NRTIs) plus 1 non-NRTI (nNRTI) remain the preferred or alternative combination antiretroviral therapy (cART) for...

Clinical characteristics of the patients initiating non-nucleoside reverse-transcriptase inhibitor-containing regimens.

Univariate analyses for factors associated with hepatotoxicity after initiation of nNRTI-containing regimens within the first 4 weeks.